Notably, without macrophage supplementation, there was no significant difference between the B16F10-Mock and B16F10-IL9 groups, and the depletion of TAMs after tumor cell and BMDM coimplantation by treatment with clodronate liposomes abolished the antitumor responses in B16F10-IL9+BMDMs. Here, IL9 is linked to neoplasm.